医学
胆汁淤积
高脂血症
骨质疏松症
维生素D与神经学
内科学
疾病
代谢性骨病
重症监护医学
维生素D缺乏
糖尿病
内分泌学
标识
DOI:10.1016/j.cld.2018.03.014
摘要
Patients with primary biliary cholangitis (PBC) are at risk for various harmful consequences of chronic cholestasis. These include fat-soluble vitamin deficiency, even in the setting of macronutrient sufficiency, as well as metabolic bone disease, including osteoporosis with fractures. Hyperlipidemia is often present and less commonly associated with risk of cardiovascular event; however, the long-term effect of new emerging therapies for PBC remains to be determined. Patients with PBC also have infrequent but notable risk of portal hypertension despite early-stage disease. This review discusses the background, evaluation, and practical management of these complications of chronic cholestasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI